May 13, 2021

Securing appropriate intellectual property protection is crucial for any innovative green tech company. However, it can be hard to keep up with the constantly evolving, and sometimes unclear, body of intellectual property law. This webinar, presented by IP litigators Deepa Acharya and Sam Stake of Quinn Emanuel Urquhart & Sullivan, will highlight recent developments in two rapidly-changing areas of intellectual property law that apply to nearly all types of green technology: patent ineligibility and trade secret protection. First, we will discuss recent Supreme Court and Federal Circuit precedent regarding the patent ineligibility of abstract ideas, as well as how these standards have been applied to the green tech industry in particular. Second, we will discuss recent developments in trade secret law, including involving the Defend Trade Secrets Act of 2016, and we will discuss lessons from recent trade secret disputes involving green tech companies.

Deepa Acharya , Partner, Quinn Emanuel Urquhart & Sullivan
Sam Stake, Partner, Quinn Emanuel Urquhart & Sullivan

For the most up-to-date event description and panelist list, as well as a link to register, go to

May 13, 2021


This conference is co-sponsored by Physicians Committee for Responsible Medicine, Johns Hopkins University, and the Environmental Law Institute.

In January 2020, California’s ban on the sale of cosmetics tested on animals went into effect. The Environmental Protection Agency announced similar efforts in September 2019 to minimize the testing of potentially harmful chemicals on most vertebrate animals by implementing New Approach Methodologies (NAMs) by 2035. While the California ban does not include certain ingredients, such as pharmaceuticals, cleaners, or other chemicals, and those required to be tested on animals by agencies such as the Food and Drug Administration (FDA), it is seen by some as a significant step in transitioning toward toxicity testing that is more relevant to the human body.

This half day workshop will discuss the opportunities and challenges in minimizing chemical tests on vertebrate animals, including the regulatory flexibility of NAMs, the gaps in information needed for implementation of NAMs, effectively communicating with relevant stakeholders, and the role of NAMs in improving the assessment of chemicals on vulnerable populations.

Tim Malloy, University of California, Los Angeles (UCLA), Co-Moderator
Kristie Sullivan, Physicians Committee for Responsible Medicine, Co-Moderator
Paul Locke, Johns Hopkins University
Rusty Thomas, Environmental Protection Agency
Joel Tickner, Association for the Advancement of Alternatives Assessment (A4)
Lauren Ziese, Ph.D., California Office of Environmental Health Hazard Assessment

Registration & More: Please visit the event page for the latest information.